KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) EBITDA (2020 - 2025)

Historic EBITDA for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $358.0 million.

  • Organon's EBITDA fell 820.51% to $358.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 62112.07%. This contributed to the annual value of $169.0 million for FY2024, which is 1985.82% up from last year.
  • As of Q3 2025, Organon's EBITDA stood at $358.0 million, which was down 820.51% from $324.0 million recorded in Q2 2025.
  • Organon's EBITDA's 5-year high stood at $390.0 million during Q3 2024, with a 5-year trough of -$579.0 million in Q4 2023.
  • Over the past 5 years, Organon's median EBITDA value was -$220.0 million (recorded in 2021), while the average stood at -$121.6 million.
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 49508.2% in 2021, then surged by 20000.0% in 2024.
  • Over the past 5 years, Organon's EBITDA (Quarter) stood at -$363.0 million in 2021, then crashed by 33.06% to -$483.0 million in 2022, then decreased by 19.88% to -$579.0 million in 2023, then skyrocketed by 149.74% to $288.0 million in 2024, then grew by 24.31% to $358.0 million in 2025.
  • Its EBITDA stands at $358.0 million for Q3 2025, versus $324.0 million for Q2 2025 and $239.0 million for Q1 2025.